Interface Biologics Inc. Company Profile

08:17 EST 24th November 2017 | BioPortfolio

News Articles [545 Associated News Articles listed on BioPortfolio]

Medical News Today: What are biologics for RA?

Biologics work by targeting the specific immune system cells that cause rheumatoid arthritis. Learn more about biologics in this article.

Agilent/HP 35900E Interface

C $1,295.00End Date: Sunday Oct-29-2017 14:45:06 EDTBuy It Now for only: C $1,295.00Buy It Now | Add to watch list Biotech365 : Agilent/HP 35900E Interface BioMarketplace You want to propose your...

Perkin Elmer TG-IR Interface

£0.99 (0 Bids)End Date: Monday Nov-6-2017 15:11:07 GMTBid now | Add to watch list Biotech365 : Perkin Elmer TG-IR Interface BioMarketplace You want to propose your products or a Biotech Company,...

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

Biorad HRLC System Interface Model 822

EUR 262.89End Date: Monday Oct-9-2017 5:16:22 ISTBuy It Now for only: EUR 262.89Buy It Now | Add to watch list Biotech365 : Biorad HRLC System Interface Model 822 BioMarketplace You want to propo...

Heat Biologics, Inc.: Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics

DURHAM, NC / ACCESSWIRE / July 3, 2017 / Heat Biologics, Inc. ("Heat") (Nasdaq: HTBX), a leader in the development of novel therapies designed to activate a patient's immune system against cancer, ...

Samsung Bioepis Forms Novel Biologics JV with Takeda Pharma

Samsung Bioepis, a division of Samsung Biologics, announced a joint venture with Japan's Takeda Pharma to develop novel biologic drugs. The JV's first project will be TAK-671, a candidate aimed at sev...

Straining the memory: Prototype strain engineered materials are the future of data storage

Researchers from the Singapore University of Technology and Design (SUTD) and Shanghai Institute of Microsystems and Information Technology have nano-engineered a superlattice data storage material. D...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Pytest [Avent, Inc.]

PYtest (C-Urea Capsules)

Pytest [Avent, Inc.]

PYtest Kit (C-Urea Breath Test)

Standardized cat pelt [Jubilant HollisterStier LLC]


Curosurf [Cornerstone Therapeutics Inc.]

CUROSURF (poractant alfa)Intratracheal Suspension

Standardized cat hair [Jubilant HollisterStier LLC]


PubMed Articles [601 Associated PubMed Articles listed on BioPortfolio]

Prolongation of biologic dosing intervals in patients with stable psoriasis: a feasibility study.

Biologics are usually licensed according to the "one dose fits all" principle. It is therefore suspected that a significant number of psoriasis patients are overtreated. However, evidence for successf...

Biosimilars: biologics that meet patients' needs and healthcare economics.

Biologics have revolutionized medical care, yet uniform access to these effective medicines remains difficult due to the increasing costs of healthcare. As patent exclusivity on the early biologics wa...

The expanding field of biologics in the management of chronic urticaria.

Chronic urticaria (CU) is the occurrence of urticaria with or without angioedema for at least 6 weeks. Management has traditionally involved antihistamines as first-line therapy with various alternati...

Biologics for idiopathic inflammatory myopathies.

As treatment of refractory cases of idiopathic inflammatory myopathies (IIMs) has been challenging, there is growing interest in assessing novel biologics that target various pathways implicated in th...

Severe subcutaneous hematoma in a patient with psoriatic arthritis: Changes of platelet count in psoriatic patients with biologic agents.

The effectiveness of biologics has changed therapeutic strategies for psoriasis dramatically, but biologics are known to have various adverse effects. We report a 63-year-old woman with psoriatic arth...

Clinical Trials [226 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Interface Selection for Adaptive Servo Ventilation

The purpose of this study is to compare the effects of nasal and oronasal interfaces during ASV treatment on sleep efficiency and sleep architecture. Therefore, patients starting treatment...

Companies [376 Associated Companies listed on BioPortfolio]

Interface Biologics Inc.

Interface Biologics

Toronto, Canada – August 26, 2005 - Interface Biologics Inc. announced today the appointment of Richard W. Sullivan to the position of President and Chief Executive Officer of the Company.Mr. Sulliv...

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

More Information about "Interface Biologics Inc." on BioPortfolio

We have published hundreds of Interface Biologics Inc. news stories on BioPortfolio along with dozens of Interface Biologics Inc. Clinical Trials and PubMed Articles about Interface Biologics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Interface Biologics Inc. Companies in our database. You can also find out about relevant Interface Biologics Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record